retatrutide sleepy VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide (RETA) – 10mg -

Placing the vial behind other items in the fridge provides additional light protection when the door opens

GLP-1 medications primarily target fat reduction, not muscle breakdown

Consumer Information Use and Disclaimer This information should not be used to decide whether or not to take this medicine or any other medicine

Review the injection site reaction guide for detailed management advice

Receptor Pharmacology in Research Contexts Non-clinical characterization published by third parties describes uneven activity across the three targets, with reported potency at the GIP receptor exceeding that observed at the glucagon and GLP-1 receptors when measured against their endogenous ligands

Weigh the risks of side effects Despite reports of some serious side effects, Levy says these medications have a pretty solid safety record